Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to -$0.85.

  • Bicycle Therapeutics' EPS (Weighted Average and Diluted) fell 1486.49% to -$0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.62, marking a year-over-year decrease of 1104.29%. This contributed to the annual value of -$2.9 for FY2024, which is 4279.0% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported EPS (Weighted Average and Diluted) of -$0.85 as of Q3 2025, which was down 1486.49% from -$1.14 recorded in Q2 2025.
  • Bicycle Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.59 during Q3 2021, with a 5-year trough of -$1.41 in Q2 2023.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.94, with a median of -$0.89 in 2024.
  • In the last 5 years, Bicycle Therapeutics' EPS (Weighted Average and Diluted) plummeted by 6271.19% in 2022 and then skyrocketed by 5199.01% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.72 in 2021, then tumbled by 40.43% to -$1.01 in 2022, then plummeted by 36.49% to -$1.38 in 2023, then soared by 35.42% to -$0.89 in 2024, then grew by 4.59% to -$0.85 in 2025.
  • Its last three reported values are -$0.85 in Q3 2025, -$1.14 for Q2 2025, and -$0.88 during Q1 2025.